COMPUTATIONAL INVESTIGATION OF INHIBITOR BINDING TO THE ENZYME SARCO/ENDOPLASMI
抑制剂与酶 SARCO/ENDOPLASMI 结合的计算研究
基本信息
- 批准号:8364343
- 负责人:
- 金额:$ 0.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-15 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressBindingBinding SitesBiological AssayBiomedical ResearchCa(2+)-Transporting ATPaseComputersEndoplasmic ReticulumEnvironmentEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesExerciseFundingFutureGrantHigh Performance ComputingHydroquinonesInvestigationKentuckyMalignant neoplasm of prostateMembraneNational Center for Research ResourcesPharmaceutical PreparationsPhysiological ProcessesPotential EnergyPrincipal InvestigatorProcessPropertyQuantum MechanicsResearchResearch InfrastructureResourcesRoleRunningSeriesSimulateSourceSupercomputingSurfaceSystemTestingTimeUnited States National Institutes of HealthUniversitiesWatercomputational chemistrycosthydroquinoneimprovedinhibitor/antagonistmolecular dynamicsnovelquantumsimulationsupercomputertool
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Inhibitors of the enzyme sarco/endoplasmic reticulum calcium-ATPase (SERCA) are valuable research tools for the study of the enzymes role in physiological processes and they also have the potential of being developed into agents against prostate cancer. A series of hydroquinone derivatives, a new class of SERCA inhibitors, have been synthesized and their ability to inhibit the enzyme has been assessed in bioassays. Molecular dynamics simulations are planned that will help identify the binding mode of these inhibitors in SERCAs binding site, which, in turn, will allow the determination of crucial enzyme/inhibitor interactions. Information gained from the simulations will guide the future synthesis of novel compounds with improved properties. Since the computational requirements for the simulations exceed the resources available to us at Northern Kentucky University, we hope to be granted access to the TeraGrid supercomputer facility. The molecular dynamics simulations of SERCA enzyme system is a highly computer intensive effort. Identifying a supercomputing facility with parallel efficient multi-core processing such as the TeraGrid supercomputing facility is the best way to address our computing needs.The SERCA/inhibitor/membrane/water system consists of ~50,000 atoms and the system needs to be simulated for not less than 5ns in order to study the inhibitor/SERCA interacting mechanism. Moreover, to have statistical confidence in the results we need to run many simulations with distinct initial conditions. We have already performed a test run of the system in dual-quad core workstation, which uses a MPI parallel environment and parallel capabilities in the Charmm package. This preliminary exercise gave us a manageable computing time of 2 weeks for a one run of the system and we plan to perform further simulations of the system. Furthermore, the drug-like inhibitor compounds needs to be parametrized and optimized using Quantum Mechanics package such as Gaussian prior to start the MD simulations. Initially, we expect to use Gaussian computational chemistry package in TeraGrid supercomputing center for our research. The parametrization and optimization need the quantum simulations of about 25 atoms compounds with MP2 level and specifically, we need to run potential energy surfaces and energy optimizations. We seek the computing facility as a startup allocation in TeraGrid to run our Gaussian script for the parameters optimization for Molecular Dynamics simulations of the SERCA/inhibitor systems.
这个子项目是利用这些资源的众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stefan Franz Paula其他文献
Stefan Franz Paula的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stefan Franz Paula', 18)}}的其他基金
Development of phenolic small molecule inhibitors of PfATP6, a Plasmodium calcium ATPase
疟原虫钙 ATP 酶 PfATP6 酚类小分子抑制剂的开发
- 批准号:
10627419 - 财政年份:2023
- 资助金额:
$ 0.11万 - 项目类别:
REQUEST FOR SUPPORT OF A TEACHING POSTDOCTORAL FELLOW
请求博士后教学人员的支持
- 批准号:
8360110 - 财政年份:2011
- 资助金额:
$ 0.11万 - 项目类别:
SERCA INHIBITION BY HYDROQUINONE DERIVATIVES
氢醌衍生物对 SERCA 的抑制作用
- 批准号:
8168286 - 财政年份:2010
- 资助金额:
$ 0.11万 - 项目类别:
Hydroquinone derivatives as novel calcium ATPase inhibitors
对苯二酚衍生物作为新型钙 ATP 酶抑制剂
- 批准号:
8495002 - 财政年份:2009
- 资助金额:
$ 0.11万 - 项目类别:
ANALYSIS OF 25-DIALKYL HYDROQUINONES AS NOVEL ENZYME INHIBITORS
25-二烷基氢醌作为新型酶抑制剂的分析
- 批准号:
7960117 - 财政年份:2009
- 资助金额:
$ 0.11万 - 项目类别:
ANALYSIS OF 25-DIALKYL HYDROQUINONES AS NOVEL ENZYME INHIBITORS
25-二烷基氢醌作为新型酶抑制剂的分析
- 批准号:
7720141 - 财政年份:2008
- 资助金额:
$ 0.11万 - 项目类别:
DEVELOPMENT OF NOVEL HYDROQUINONE-BASED SERCA INHIBITORS
新型氢醌 SERCA 抑制剂的开发
- 批准号:
7610397 - 财政年份:2007
- 资助金额:
$ 0.11万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
- 批准号:
24K15172 - 财政年份:2024
- 资助金额:
$ 0.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
- 批准号:
23K04928 - 财政年份:2023
- 资助金额:
$ 0.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
- 批准号:
10744934 - 财政年份:2023
- 资助金额:
$ 0.11万 - 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
- 批准号:
573688-2022 - 财政年份:2022
- 资助金额:
$ 0.11万 - 项目类别:
University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10704557 - 财政年份:2022
- 资助金额:
$ 0.11万 - 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10537846 - 财政年份:2022
- 资助金额:
$ 0.11万 - 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
- 批准号:
2753921 - 财政年份:2022
- 资助金额:
$ 0.11万 - 项目类别:
Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
- 批准号:
10328140 - 财政年份:2022
- 资助金额:
$ 0.11万 - 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
- 批准号:
10621368 - 财政年份:2021
- 资助金额:
$ 0.11万 - 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
- 批准号:
2111821 - 财政年份:2021
- 资助金额:
$ 0.11万 - 项目类别:
Standard Grant














{{item.name}}会员




